Article Details
Retrieved on: 2024-04-14 17:30:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Robert James Wills, a director at Oncternal Therapeutics Inc (NASDAQ:ONCT), bought 3086 shares of Oncternal Therapeutics Inc (NASDAQ:ONCT) at ...
Article found on: www.insidermonkey.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here